ARV Pellet Implant with Levonorgestrel
The ARV Pellet Implant with levonorgestrel is a long-acting multipurpose prevention technology implantable product developed by CONRAD combining an ARV, for HIV prevention, and levonorgestrel, for contraception, in a biodegradable subdermal pellet system. This product is a low-cost, biodegradable subdermal pellet-type implant system that provides tightly controlled, long-acting sustained release of its payload, is highly tunable, and does not require surgical removal.
For more information, contact: Gustavo Doncel at doncelgf@odu.edu / conradinnovations@odu.edu
Development Stage:
Preclinical – Early (Pre1)
Hormonal/Non-Hormonal:
Hormonal
Delivery Route & Method:
Systemic - Implant (Subcutaneous)
Mechanism of Action:
Integrase strand-transfer inhibitor; progestrin
Developer:
- CONRAD
Funding:
- Unspecified
Past Funding:
U.S Agency for International Development (USAID)
Eastern Virginia Medical School (EVMS), now part of Virginia Health Sciences at Old Dominion University
Active Ingredient(s):
- Levonorgestrel
- ARV (unspecified)
Product Indication(s):
- HIV
- Unintended Pregnancy
Useful Links: